• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Automated microkeratome offers versatility with 3 ring sizes

Article

New Orleans-The BD K-3000 Microkeratome (Becton Dickinson Ophthalmic Systems, Franklin Lakes, NJ) is a reliable and safe system for flap creation during LASIK, according to Paul Dougherty, MD, medical director, Dougherty Laser Vision Institute, Camarillo, CA.

Related Videos
Related Content
Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410

Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
Intracortical Visual Prosthesis achieves 2 years of successful testing

Intracortical Visual Prosthesis achieves 2 years of successful testing

Article
EyePod: Modifier Gene Therapy: What is it?

EyePod: Modifier Gene Therapy: What is it?

Podcast
Using extracellular vesicles in the treatment of ocular diseases

Using extracellular vesicles in the treatment of ocular diseases

Article
Ocular Therapeutix announces positive topline Phase 1 data for Axpaxli in diabetic retinopathy

Ocular Therapeutix announces positive topline Phase 1 data for Axpaxli in diabetic retinopathy

Article
© 2024 MJH Life Sciences

All rights reserved.